Retraction Note: Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation
- PMID: 39663284
- DOI: 10.1007/s13346-024-01761-0
Retraction Note: Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation
Retraction of
-
Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation.Drug Deliv Transl Res. 2022 Mar;12(3):615-628. doi: 10.1007/s13346-021-00971-0. Epub 2021 May 19. Drug Deliv Transl Res. 2022. Retraction in: Drug Deliv Transl Res. 2025 Apr;15(4):1455. doi: 10.1007/s13346-024-01761-0. PMID: 34013457 Retracted.
References
-
- Abstracts of the 26th Annual Conference of APASL, February 15–19. 2017, Shanghai, China. Hepatol Int. 2017;11(Suppl 1):1–1093:765. https://doi.org/10.1007/s12072-016-9783-9
-
- Singhal T, et al. Preparation, optimization and biological evaluation of gymnemic acid loaded niosomes against streptozotocin-nicotinamide induced diabetic-nephropathy in Wistar rats. J Drug Deliv Sci Technol. 2019;54:101328. https://doi.org/10.1016/j.jddst.2019.101328 . - DOI
Publication types
LinkOut - more resources
Full Text Sources
